Risk Factors of Disseminated Tumor Cells in the Bone Marrow of Patients With Angioimmunoblastic T‐Cell Lymphoma and Their Impact on Prognosis
International Journal of Laboratory Hematology · 2026-08 · 48 (4) · 823-830
DOI: 10.1111/ijlh.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 09.04.2026. Verfasst von Dongyao Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Bone Marrow, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Neoplastic Cells, Circulating. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Angioimmunoblastic T‐cell lymphoma (AITL) is a mature T‐cell proliferative tumor characterized by an aggressive clinical course and low incidence. The risk factors for the presence of disseminated tumor cells (DTCs) in the bone marrow (BM) of patients and their impact on prognosis remain incompletely understood. In this study, we used multiparametric flow cytometry (MFC) to detect DTCs in the BM of AITL patients. We aimed to assess risk factors for the presence of DTCs, investigate correlations between the immunophenotype of DTCs and clinical indicators or efficacy, and identify prognostic factors. Our findings provide insights that may aid in the early diagnosis, disease monitoring, and efficacy evaluation of AITL.
Methods
Based on the presence or absence of DTCs in the BM, 90 patients with an initial diagnosis of AITL were classified into DTCs + and DTCs − groups. The differences between the two groups were then compared. Clinical and survival data were collected from AITL patients to analyze the correlations between immunophenotypes and clinical characteristics or prognosis. Univariate logistic regression was employed to analyze the factors influencing efficacy.
Results
MFC detected neoplastic T cells of AITL in 65.56% (59/90) of BM samples. Compared to the DTCs − patients, DTCs + patients had a higher frequency of fever, splenomegaly, extranodal involvement ≥ 2 sites, and elevated lactate dehydrogenase (LDH). The 2‐year progression‐free survival (PFS) rates were 31.3% and 52.5%, and the 2‐year overall survival (OS) rates were 65.6% and 65.3% in the DTCs + and DTCs − groups, respectively. Multivariate survival analysis demonstrated that pleural effusion was a risk factor affecting PFS and OS. Furthermore, loss of CD7 expression on DTCs was associated with shorter OS. AITL patients with CD7 loss were more likely to present with rash, elevated immunoglobulins, and CXCL13 loss by histopathological immunohistochemistry. Finally, CD3 expression, elevated LDH, and decreased hemoglobin (HGB) were collectively identified as high‐risk factors for disease progression.
Conclusion
The presence of DTCs in the BM is associated with the prognosis of AITL. Pleural effusion constitutes an independent adverse prognostic factor. Loss of CD7 correlates with shorter OS, and a profile combining CD3 expression, elevated LDH, and decreased HGB serves as a useful predictor of disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Key Clinical Laboratory of Henan Province, Zhengzhou, Henan, China.
- Hematologic Oncology, Henan Children's Hospital, Zhengzhou, Henan, China.
- School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
- Faculty of Laboratory Medicine, Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Baohong Yue
Zitieren
APA
Yan, D., Cao, X., Wang, X., & Yue, B. (2026). Risk Factors of Disseminated Tumor Cells in the Bone Marrow of Patients With Angioimmunoblastic T‐Cell Lymphoma and Their Impact on Prognosis. International Journal of Laboratory Hematology, 48(4), 823-830. https://doi.org/10.1111/ijlh.70112
Vancouver
Yan D, Cao X, Wang X, Yue B. Risk Factors of Disseminated Tumor Cells in the Bone Marrow of Patients With Angioimmunoblastic T‐Cell Lymphoma and Their Impact on Prognosis. International Journal of Laboratory Hematology. 2026;48(4):823-830. doi:10.1111/ijlh.70112
BibTeX
@article{Yan2026,
author = {Yan, Dongyao and Cao, Xueyan and Wang, Xiaoqian and Yue, Baohong},
title = {Risk Factors of Disseminated Tumor Cells in the Bone Marrow of Patients With Angioimmunoblastic T‐Cell Lymphoma and Their Impact on Prognosis},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {4},
pages = {823--830},
doi = {10.1111/ijlh.70112}
}
EUVIMED